Article
Organometallics, Vol. 28, No. 13, 2009 3895
Ar-H); 7.27-7.06 (m, 4H, Ar-H); 7.60-7.53 (m, 6H, Ar-H);
7.64-7.68 (m, 3H, Ar-H); 7.98 (t, JH-H= 9.0 Hz, 6H, Ar-H).
13C NMR (100.6 MHz; CD2Cl2): δ 21.00 (s, CH3); 121.74
(s, CH); 125.31 (s, CH); 126.12 (s, C); 127.14 (s, C); 128.87
(s, CH); 128.34 (s, CH); 128.89 (s, CH); 129.02 (s, CH); 129.59
(10 mL) at room temperature. The yellow solution immediately
turned orange. The orange solution was heated at 50 °C for 18 h.
Hexane (10 mL) was added to this solution to precipitate
complex 1 as an orange solid, which was isolated by filtration
and dried in vacuo (12.5 mg, 79%).
(s, CH); 129.88 (s, CH); 132.15 (s, CH); 133.39 (d, JC-P=
4.0 Hz, CH); 134.35 (s, C); 134.73 (s, CH); 136.00 (s, CH);
Conversion of 4 into 2. Dilute HCl Et2O (1.50 M, 11 μL,
3
0.023 mmol) was added dropwise via syringe to a solution of
4 (10 mg, 0.021 mmol) in CHCl3 (10 mL) at room temperature.
The yellow solution immediately turned orange. The orange
solution was stirred at room temperature for 18 h. Hexane
(10 mL) was added to this solution to precipitate complex 2 as
an orange solid, which was isolated by filtration and dried in
vacuo (9.0 mg, 85%).
146.59 (s, C); 146.81 (s, C); 154.21 (s, C); 175.26 (s, C). 31P NMR
(121.5 MHz; CD2Cl2):
δ
34.28 (s). IR (Nujol, cm-1):
1551 (νCN), 1251 (νNP). Anal. Calcd for C38H31N2PCl2Pd
(723.97): C, 63.04; H, 4.32; N, 3.87. Found: C, 61.94; H, 4.35;
N, 3.78. MS (EI, m/z): calcd mass 684.08864; obsd mass
684.08754 ((M - HCl)+).
L0MesPdCl (3). A round-bottomed flask was loaded with
1 (100 mg, 0.13 mmol) and NaOAc (16 mg, 1.5 equiv, 0.2 mmol).
Chloroform (25 mL) was added, and the orange suspension was
refluxed vigorously for 48 h. The resulting yellow solution was
filtered through Celite, and hexane was (∼5 mL) added until a
yellow solid began to precipitate. The mixture was then stirred
for 18 h at room temperature and filtered, and the resulting
yellow solid dried under vacuum, to yield complex 3 (70 mg,
74%). A single crystal suitable for X-ray crystallography
was grown by slow diffusion of ether into a solution of 3 in
[L0MesPd(NCCH3)][BF4] (5). A Schlenk flask was loaded with
3 (100 mg, 0.14 mmol) and NaBF4 (150 mg, 1.4 mmol).
Dichloromethane (10 mL) and acetonitrile (1 mL) were added,
and the reaction was stirred at room temperature for 18 h.
Addition of hexane (2 mL) produced a yellow precipitate, which
was filtered and dried in vacuo to yield 5 (97 mg, 86%). A single
crystal of 5 suitable for X-ray crystallography was grown from
slow evaporation from CH2Cl2 at room temperature 1H NMR
(300.1 MHz; CD2Cl2): δ 1.80 (s, 3H, CH3CN); 1.99 (s, 6H, Mes σ
CH3); 2.13 (s, 3H, Mes p-CH3); 6.69-6.77 (m, 4H, Ar-H); 6.96
(t, J = 9.9 Hz, 2H, Ar-H); 7.05 (d, J = 6.9 Hz, 2H, Ar-H); 7.15
(t, J = 8.4 Hz, 1H, Ar-H); 7.24-7.34 (m, 6H, Ar-H); 7.62-7.82
(m, 10H, Ar-H). 13C NMR (100.6 MHz; CD2Cl2): δ 3.19
(s, NCCH3); 19.76 (s, σ CH3); 21.54 (s, p-CH3); 120.21
(s, NCCH3); 121.90 (s, CH); 127.42 (s, CH); 128.31 (s, CH);
128.75 (s, CH); 129.43 (s, CH); 129.59 (s, CH); 129.61 (s, C);
129.86 (s, C); 130.58 (s, CH); 130.70 (s, CH); 130.76 (s, CH);
130.88 (s, CH); 131.30 (s, CH); 131.90 (d, JC-P = 10.4 Hz, CH);
135.26 (d, JC-P = 2.6 Hz, CH); 136.57 (s, C); 137.71 (s, CH);
1
CH2Cl2. H NMR (300.1 MHz; CD2Cl2): δ 1.99 (s, 6H, Mes
σ CH3); 2.13 (s, 3H, Mes p-CH3); 6.55-6.63 (m, 4H, Ar-H); 6.82
(m, 2H, Ar-H); 7.02 (m, 3H, Ar-H); 7.10 (t, J = 5.1 Hz, 1H,
d
t
Ar-H); 7.12-7.25 (m, 4H, Ar-H); 7.60 (dt, J = 2.1 Hz, J =
5.7 Hz, 4H, Ar-H); 7.71-7.79 (m, 6H, Ar-H); 8.08 (d, J =
6.0 Hz, 1H, Ar-H). 13C NMR (100.6 MHz; CDCl3): δ 20.40 (s,
σ CH3); 21.82 (s, p-CH3); 120.50 (s, CH); 128.16 (s, CH); 128.45
(s, CH); 128.61 (s, CH); 128.64 (s, CH); 129. 52 (s, CH); 130.00
(s, C); 130.17 (s, CH); 130.29 (S, CH); 130.67 (s, C); 130.69
(s, CH); 131.52 (s, C); 131.60 (d, JC-P = 3.2 Hz, CH); 132.24
(s, CH); 133.63 (d, JC-P= 11.3 Hz, CH); 134.14 (s, CH); 134.20
(s, CH); 134.23 (s, CH); 134.78 (s, C); 136.88 (s, CH); 137.36
(s, C); 139.66 (s, C); 147.12 (s, CH); 148.05 (d, JC-P= 3.6 Hz, C);
137.96 (s, C); 138.15 (s, C); 146.60 (s, C); 146.79 (d, JC-P
=
3.3 Hz, C); 155.39 (d, JC-P = 20.3 Hz, C-Pd); 173.46 (s, C).
31PNMR(121.5MHz;CD2Cl2): δ51.16 (s). 11B NMR (128.4 MHz,
CD2Cl2): δ 1.22 (s). IR (Nujol, cm-1): 1545 (νCN), 1228 (νNP).
Anal. Calcd for C42H37N3PBF4Pd (807.96): C, 62.43; H, 4.62;
N, 5.20. Found: C, 61.96; H, 4.60; N, 5.20. MS (ESI, m/z):
calcd mass 677.1500; obsd mass 677.1515 [(M - MeCN, - BF4)].
[L0TolPd(NCCH3)][BF4] (6). Complex 6 was made in an
identical manner to 5, using 4 (100 mg, 0.14 mmol) instead.
The reaction yielded a dark yellow solid of 6 (97 mg, 86%).
1H NMR (300.1 MHz; CD2Cl2): δ 1.87 (s, 3H, CH3CN); 2.22
(s, 3H, pTol-CH3); 6.61 (d, J = 8.4 Hz, 1H, Ar-H); 6.72 (t, J =
8.0 Hz, 1H, Ar-H); 6.92 (t, J = 6.8 Hz, 1H, Ar-H); 6.99 (d, J =
8.4 Hz, 2H, Ar-H); 7.09 (m, 4H, Ar-H); 7.29 (m, 8H, Ar-H), 7.68
(m, 4H, Ar-H); 7,84 (m, 6H, Ar-H). 13C NMR (100.6 MHz;
CD2Cl2): δ 2.71 (s, NCCH3); 20.84 (s, p-CH3); 120.20 (s, NCCH3);
120.77 (s, CH); 123.26 (s, CH); 127.49 (s, C); 128.21 (s, CH); 128.35
(s, C); 128.60 (s, CH); 128.73 (s, CH); 129.06 (s, CH); 129.84
(s, CH); 129.88 (s, CH); 130.01 (s, CH); 132.50 (s, CH); 132.71
2
157.62 (d, JC-P= 20 Hz, C-Pd); 171. 68 (s, C). 31P NMR
(121.5 MHz; CD2Cl2): δ 41.62 (s). IR (Nujol, cm-1): 1546 (νCN),
1234 (νNP). Anal. Calcd for C40H34N2PClPd (715.57): C, 67.12;
H, 4.79; N, 3.91. Found: C, 66.94; H, 4.81; N, 3.86. MS (EI, m/z):
calcd mass 712.1186; obsd mass 712.1188 (M).
L0TolPdCl (4). A round-bottemed flask was loaded with
complex 2 (100 mg, 0.13 mmol) and NaOAc (16 mg, 0.2 mmol).
Chlorobenzene (25 mL) was added, and the orange suspension
was refluxed vigorously for 24 h. The resulting yellow solution
was filtered through Celite, and hexane was added until a yellow
solid began to precipitate. The mixture was then stirred for 18 h
at room temperature and filtered, and the resulting yellow solid
dried in vacuo to yield complex 4 (70 mg, 74%). 1H NMR (300.1
MHz; CD2Cl2): δ 1.99 (s, 3H, pTol-CH3); 6.38 (d, J = 8.4 Hz,
1H, Ar-H); 6.60 (t, J = 7.8 Hz, 1H, Ar-H); 6.68 (m, 2H, Ar-H);
6.84 (m, 4H, Ar-H); 7.17 (m, 8H, Ar-H); 7.63 (m, 4H, Ar-H);
7.74 (m, 2H, Ar-H); 7.87 (m, 4H, Ar-H); 7.99 (d, J = 7.5 Hz, 1H,
Ar-H). 13C NMR (100.6 MHz; CDCl3): δ 21.51 (s, p-CH3);
120.50 (s, CH); 123.26 (d, JC-P = 7.6 Hz, CH); 124.87 (s, CH);
125.01 (s, CH); 128.59 (d, JC-P = 10.1 Hz, CH); 129.22 (s, CH);
(s, CH); 133.17 (d, JC-P = 10.3 Hz, CH); 134.43 (d, JC-P
=
10.3 Hz, CH); 135.36 (s, C); 136.90 (s, CH); 137.11 (s, CH);
137.15 (s, C); 138.05 (s, C); 145.57 (s, C); 147.92 (s, C); 153.87
(d, JC-P = 20.2 Hz, C-Pd); 173.69 (s, C). 31P NMR (121.5 MHz;
CD2Cl2): δ 49.71 (s). 11B NMR (128.4 MHz, CD2Cl2): δ -1.04 (s).
IR (Nujol, cm-1): 1545 (νCN), 1221 (νNP). Anal. Calcd for
C40H33N3PBF4Pd (779.91): C, 61.60; H, 4.26; N, 5.39. Found: C,
61.63; H, 4.81; N, 4.96. MS (ESI, m/z): calcd mass 677.1500; obsd
mass 677.1515 [(M - MeCN, - BF4)].
129.92 (s, CH); 130.23 (s, CH); 130.35 (s, CH); 131.20 (d, JC-P
=
3.7 Hz, CH); 132.65 (s, CH); 133.24 (d, JC-P = 11.7 Hz, C);
134.13 (d, JC-P = 10.3 Hz, CH); 134.46 (d, JC-P = 2.7 Hz, CH);
134.81 (s, C); 136.69 (s, CH); 137.93 (s, C); 139.31 (s, C); 139.55
(s, CH); 139.60 (s, C); 139.70 (s, CH); 147.82 (s, C); 148.68 (s, C);
2
157.59 (d, JC-P = 19.4 Hz, C-Pd); 173.18 (s, C). 31P NMR
Acknowledgment. The authors thank UBC, NSERC,
CFI, and BCKDF for funding. We also thank Prof. Peter
Legzdins for valuable discussions.
(121.5 MHz; CD2Cl2): δ 36.16 (s). IR (Nujol, cm-1): 1543 (νCN),
1241 (νNP). Anal. Calcd. for C38H30N2PClPd CH2Cl2 (772.44):
3
C, 60.59; H, 4.18; N, 3.63. Found: C, 60.10; H, 3.82; N, 3.50. MS
(EI, m/z): calcd mass 712.1186; obsd mass 712.1188 (M).
Reversible Orthopalladation: Conversion of 3 into 1. Dilute
Supporting Information Available: Crystallographic informa-
tion files (CIF). This material is available free of charge via the
HCl Et2O (1.68M, 12 μL, 0.020) was added dropwise via
syringe to a solution of 3 (15 mg, 0.021 mmol) in CHCl3
3